1 study found for:    23562009 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy Study of Daclizumab High Yield Process to Treat Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-remitting
Interventions: Biological: Daclizumab High Yield Process;   Other: placebo

Indicates status has not been verified in more than two years